Francisca Sabugo

525 total citations
18 papers, 400 citations indexed

About

Francisca Sabugo is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Francisca Sabugo has authored 18 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Francisca Sabugo's work include Vasculitis and related conditions (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Francisca Sabugo is often cited by papers focused on Vasculitis and related conditions (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Francisca Sabugo collaborates with scholars based in Chile, Netherlands and Canada. Francisca Sabugo's co-authors include M Cuchacovich, Lilian Soto, Diego Catalán, Juan Carlos Aguillón, Bárbara Pesce, Octavio Aravena, Marı́a Carmen Molina, Pablo H. Sotelo, Mercedes López and H Gatica and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Clinical & Experimental Immunology.

In The Last Decade

Francisca Sabugo

17 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisca Sabugo Chile 9 205 170 74 53 52 18 400
Dao X. Nguyen United Kingdom 9 121 0.6× 236 1.4× 32 0.4× 64 1.2× 69 1.3× 9 410
A. R. van der Horst Netherlands 12 388 1.9× 177 1.0× 194 2.6× 76 1.4× 38 0.7× 22 592
H. Alrayes Saudi Arabia 8 313 1.5× 338 2.0× 76 1.0× 39 0.7× 135 2.6× 13 560
R. A. Moura Portugal 13 286 1.4× 259 1.5× 119 1.6× 101 1.9× 103 2.0× 27 578
Martin van Hagen Netherlands 7 109 0.5× 105 0.6× 29 0.4× 28 0.5× 33 0.6× 16 284
M Canova Italy 5 185 0.9× 160 0.9× 32 0.4× 33 0.6× 55 1.1× 5 370
L. Matarán Spain 13 252 1.2× 272 1.6× 120 1.6× 69 1.3× 142 2.7× 17 551
L Pepper United Kingdom 9 231 1.1× 128 0.8× 74 1.0× 229 4.3× 79 1.5× 9 503
J R Kalden Germany 6 217 1.1× 121 0.7× 78 1.1× 99 1.9× 64 1.2× 7 383
Gudrun Steinhauser Germany 6 188 0.9× 422 2.5× 148 2.0× 31 0.6× 43 0.8× 9 645

Countries citing papers authored by Francisca Sabugo

Since Specialization
Citations

This map shows the geographic impact of Francisca Sabugo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisca Sabugo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisca Sabugo more than expected).

Fields of papers citing papers by Francisca Sabugo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisca Sabugo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisca Sabugo. The network helps show where Francisca Sabugo may publish in the future.

Co-authorship network of co-authors of Francisca Sabugo

This figure shows the co-authorship network connecting the top 25 collaborators of Francisca Sabugo. A scholar is included among the top collaborators of Francisca Sabugo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisca Sabugo. Francisca Sabugo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sabugo, Francisca, et al.. (2022). Cranial versus Extracranial Involvement in Giant Cell Arteritis: 15 Years Retrospective Cohort Analysis. Open Access Rheumatology Research and Reviews. Volume 14. 97–101. 3 indexed citations
2.
Sabugo, Francisca, et al.. (2020). Interstitial lung disease and microscopic polyangiitis in chilean patients.. PubMed. 37(1). 37–42. 3 indexed citations
3.
Castro, Ariel, H Gatica, Pilar Carrasco‐Garrido, et al.. (2019). AB0325 PREVALENCE OF ANXIETY/DEPRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS AT THE UNIVERSITY OF CHILE'S CLINICAL HOSPITAL AND THEIR ASSOCIATIONS WITH DISSEASE ACTIVITY INDEXES AND QUALITY OF LIFE. Annals of the Rheumatic Diseases. 78. 1620–1621. 1 indexed citations
4.
Molina, M., et al.. (2018). AB0691 Instertitial lung disease and mycroscopic polyangiitis in chilean patients. Annals of the Rheumatic Diseases. 77. 1487–1488. 2 indexed citations
5.
Alcayaga, Gonzalo Rojas, et al.. (2016). Illness Experiences in Women with Oral Dryness as a Result of Sjögren's Syndrome: The Patient Point of View. Musculoskeletal Care. 14(4). 233–242. 7 indexed citations
6.
Sabugo, Francisca, et al.. (2014). Aortitis, causas infrecuentes en Reumatología: presentación de casos. Revista médica de Chile. 142(7). 924–929.
7.
Sabugo, Francisca, et al.. (2013). Acute Herpes Simplex Virus 1 Pneumonitis in a Patient With Systemic Lupus Erythematosus. JCR Journal of Clinical Rheumatology. 20(1). 42–44. 8 indexed citations
8.
Pesce, Bárbara, Lilian Soto, Francisca Sabugo, et al.. (2012). Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients. Clinical & Experimental Immunology. 171(3). 237–242. 97 indexed citations
9.
Aravena, Octavio, Bárbara Pesce, Lilian Soto, et al.. (2011). Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets. Immunobiology. 216(12). 1256–1263. 50 indexed citations
11.
Catalán, Diego, Octavio Aravena, Roberto Ariel Abeldaño Zúñiga, et al.. (2011). Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles. Rheumatology International. 32(6). 1819–1825. 6 indexed citations
12.
Cuchacovich, M, et al.. (2010). Comparison of the Clinical Efficacy of Two Different Immunosuppressive Regimens in Patients with Chronic Vogt-Koyanagi-Harada Disease. Ocular Immunology and Inflammation. 18(3). 200–207. 37 indexed citations
13.
Catalán, Diego, Octavio Aravena, Francisca Sabugo, et al.. (2010). B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy. Arthritis Research & Therapy. 12(2). R68–R68. 44 indexed citations
14.
Dí­az, Gonzalo, et al.. (2009). Enfermedad de Behçet en Chile: Análisis clínico de 44 casos. Revista médica de Chile. 137(10). 1333–40. 3 indexed citations
15.
Cuchacovich, M, Diego Catalán, H Gatica, et al.. (2009). Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis.. PubMed. 26(6). 1067–73. 29 indexed citations
16.
Sabugo, Francisca, Claudio Liberman, J.P. Niedmann, Lilian Soto, & M Cuchacovich. (2007). Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism. Clinical Rheumatology. 27(4). 533–535. 22 indexed citations
17.
Cuchacovich, M, Lilian Soto, M Edwardes, et al.. (2006). Tumour necrosis factor (TNF)α −308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology. 35(6). 435–440. 65 indexed citations
18.
Llanos, Carolina, Lilian Soto, Francisca Sabugo, et al.. (2006). Systemic vasculitis associated withFasciola hepaticainfection. Scandinavian Journal of Rheumatology. 35(2). 143–146. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026